Amgen Loses Bid To Wrap Up Teva Patent Fight
Pharmaceutical giant Amgen Inc. has lost its bid for partial summary judgment in a patent spat launched by Teva Pharmaceuticals USA Inc. as part of its effort to market a generic...To view the full article, register now.
Already a subscriber? Click here to view full article